Geriatric Medicines Market Report

China Geriatric Medicines Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：201
  • REPORT CODE：GMM1805030
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Geriatric Medicines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sanofi SA

    • Eli Lilly and Company

    • AstraZeneca plc

    • Bristol-Myers Squibb Company

    • Pfizer, Inc

    • Boehringer Ingelheim GmbH

    • Abbott Laboratories, Inc

    • Merck & Company Inc

    • Novartis AG

    By Type:

    • Antidiabetics

    • Antipsychotic

    • Antidepressant

    • Statins

    • Analgesics

    • Anticoagulant

    • Proton Pump Inhibitor

    • Antihypertensive

    By Application:

    • Respiratory

    • Arthritis

    • Cardiovascular

    • Osteoporosis

    • Neurological

    • Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Geriatric Medicines Market Overview 2018-2029

    • 1.1 China Geriatric Medicines Industry Development Overview

    • 1.2 China Geriatric Medicines Industry Development History

    • 1.3 China Geriatric Medicines Industry Market Size (2018-2029)

    • 1.4 China Geriatric Medicines Market Analysis by Type from Production Side

      • 1.4.1 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antidiabetics (2018-2029)

      • 1.4.2 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antipsychotic (2018-2029)

      • 1.4.3 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antidepressant (2018-2029)

      • 1.4.4 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Statins (2018-2029)

      • 1.4.5 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)

      • 1.4.6 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Anticoagulant (2018-2029)

      • 1.4.7 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Proton Pump Inhibitor (2018-2029)

      • 1.4.8 China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antihypertensive (2018-2029)

    • 1.5 China Geriatric Medicines Market Analysis by Application from Consumption End

      • 1.5.1 China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Respiratory (2018-2029)

      • 1.5.2 China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Arthritis (2018-2029)

      • 1.5.3 China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

      • 1.5.4 China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Osteoporosis (2018-2029)

      • 1.5.5 China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Neurological (2018-2029)

      • 1.5.6 China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • 1.6 China Geriatric Medicines Market Analysis by Region

      • 1.6.1 North China Geriatric Medicines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Geriatric Medicines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Geriatric Medicines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Geriatric Medicines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Geriatric Medicines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Geriatric Medicines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Geriatric Medicines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Geriatric Medicines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Geriatric Medicines Market Status and Competition Analysis in 2023

      • 2.2.3 China Geriatric Medicines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Geriatric Medicines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Geriatric Medicines Industry Development

    Chapter 3 Geriatric MedicinesIndustry Chain Analysis

    • 3.1 Geriatric Medicines Industry Chain

    • 3.2 Geriatric Medicines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Geriatric Medicines Market

    • 3.3 Geriatric Medicines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Geriatric Medicines Market

    Chapter 4 China Geriatric Medicines Market, by Type

    • 4.1 China Geriatric Medicines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Geriatric Medicines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Geriatric Medicines Production Volume and Growth Rate, by Type

      • 4.5.1 China Geriatric Medicines Production Volume and Growth Rate of Antidiabetics

      • 4.5.2 China Geriatric Medicines Production Volume and Growth Rate of Antipsychotic

      • 4.5.3 China Geriatric Medicines Production Volume and Growth Rate of Antidepressant

      • 4.5.4 China Geriatric Medicines Production Volume and Growth Rate of Statins

      • 4.5.5 China Geriatric Medicines Production Volume and Growth Rate of Analgesics

      • 4.5.6 China Geriatric Medicines Production Volume and Growth Rate of Anticoagulant

      • 4.5.7 China Geriatric Medicines Production Volume and Growth Rate of Proton Pump Inhibitor

      • 4.5.8 China Geriatric Medicines Production Volume and Growth Rate of Antihypertensive

    Chapter 5 China Geriatric Medicines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Geriatric Medicines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Geriatric Medicines Market Size and Growth Rate, by Application

      • 5.5.1 China Geriatric Medicines Market Size and Growth Rate of Respiratory

      • 5.5.2 China Geriatric Medicines Market Size and Growth Rate of Arthritis

      • 5.5.3 China Geriatric Medicines Market Size and Growth Rate of Cardiovascular

      • 5.5.4 China Geriatric Medicines Market Size and Growth Rate of Osteoporosis

      • 5.5.5 China Geriatric Medicines Market Size and Growth Rate of Neurological

      • 5.5.6 China Geriatric Medicines Market Size and Growth Rate of Cancer

    Chapter 6 China Geriatric Medicines Market, by Region

    • 6.1 China Geriatric Medicines Production Volume and Production Value, by Region

    • 6.2 China Geriatric Medicines Sales Volume and Sales Value, by Region

    Chapter 7 North China Geriatric Medicines Market Analysis

    • 7.1 North China Geriatric Medicines Market, by Type

    • 7.2 North China Geriatric Medicines Market, by Application

    Chapter 8 Central China Geriatric Medicines Market Analysis

    • 8.1 Central China Geriatric Medicines Market, by Type

    • 8.2 Central China Geriatric Medicines Market, by Application

    Chapter 9 South China Geriatric Medicines Market Analysis

    • 9.1 South China Geriatric Medicines Market, by Type

    • 9.2 South China Geriatric Medicines Market, by Application

    Chapter 10 East China Geriatric Medicines Market Analysis

    • 10.1 East China Geriatric Medicines Market, by Type

    • 10.2 East China Geriatric Medicines Market, by Application

    Chapter 11 Northeast China Geriatric Medicines Market Analysis

    • 11.1 Northeast China Geriatric Medicines Market, by Type

    • 11.2 Northeast China Geriatric Medicines Market, by Application

    Chapter 12 Southwest China Geriatric Medicines Market Analysis

    • 12.1 Southwest China Geriatric Medicines Market, by Type

    • 12.2 Southwest China Geriatric Medicines Market, by Application

    Chapter 13 Northwest China Geriatric Medicines Market Analysis

    • 13.1 Northwest China Geriatric Medicines Market, by Type

    • 13.2 Northwest China Geriatric Medicines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sanofi SA

        • 14.1.1 Sanofi SA Company Profile

        • 14.1.2 Sanofi SA Geriatric Medicines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Eli Lilly and Company

        • 14.2.1 Eli Lilly and Company Company Profile

        • 14.2.2 Eli Lilly and Company Geriatric Medicines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AstraZeneca plc

        • 14.3.1 AstraZeneca plc Company Profile

        • 14.3.2 AstraZeneca plc Geriatric Medicines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bristol-Myers Squibb Company

        • 14.4.1 Bristol-Myers Squibb Company Company Profile

        • 14.4.2 Bristol-Myers Squibb Company Geriatric Medicines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer, Inc

        • 14.5.1 Pfizer, Inc Company Profile

        • 14.5.2 Pfizer, Inc Geriatric Medicines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Boehringer Ingelheim GmbH

        • 14.6.1 Boehringer Ingelheim GmbH Company Profile

        • 14.6.2 Boehringer Ingelheim GmbH Geriatric Medicines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Abbott Laboratories, Inc

        • 14.7.1 Abbott Laboratories, Inc Company Profile

        • 14.7.2 Abbott Laboratories, Inc Geriatric Medicines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck & Company Inc

        • 14.8.1 Merck & Company Inc Company Profile

        • 14.8.2 Merck & Company Inc Geriatric Medicines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis AG

        • 14.9.1 Novartis AG Company Profile

        • 14.9.2 Novartis AG Geriatric Medicines Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Geriatric Medicines Industry Research Conclusions

    • 15.2 Geriatric Medicines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Geriatric Medicines Industry Market Size (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antidiabetics (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antipsychotic (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antidepressant (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Statins (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Anticoagulant (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Proton Pump Inhibitor (2018-2029)

    • Figure China Geriatric Medicines Production Volume, Production Value and Growth Rate of Antihypertensive (2018-2029)

    • Figure China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Respiratory (2018-2029)

    • Figure China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Arthritis (2018-2029)

    • Figure China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

    • Figure China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Osteoporosis (2018-2029)

    • Figure China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Neurological (2018-2029)

    • Figure China Geriatric Medicines Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure North China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure Central China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure South China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure East China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Geriatric Medicines Market Size and Growth Rate from 2018-2029

    • Figure Geriatric Medicines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Geriatric Medicines Market Share by Type in 2018

    • Figure China Geriatric Medicines Market Share by Type in 2023

    • Figure China Geriatric Medicines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Antidiabetics (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Antipsychotic (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Antidepressant (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Statins (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Analgesics (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Anticoagulant (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Proton Pump Inhibitor (2018-2023)

    • Figure China Geriatric Medicines Production Volume and Growth Rate of Antihypertensive (2018-2023)

    • Figure China Geriatric Medicines Market Share by Application in 2018

    • Figure China Geriatric Medicines Market Share by Application in 2023

    • Figure China Geriatric Medicines Total Market Size and Growth Rate from Consumption End

    • Figure China Geriatric Medicines Market Size and Growth Rate of Respiratory (2018-2023)

    • Figure China Geriatric Medicines Market Size and Growth Rate of Arthritis (2018-2023)

    • Figure China Geriatric Medicines Market Size and Growth Rate of Cardiovascular (2018-2023)

    • Figure China Geriatric Medicines Market Size and Growth Rate of Osteoporosis (2018-2023)

    • Figure China Geriatric Medicines Market Size and Growth Rate of Neurological (2018-2023)

    • Figure China Geriatric Medicines Market Size and Growth Rate of Cancer (2018-2023)

    • Table China Geriatric Medicines Production Volume by Region (2018-2023)

    • Table China Geriatric Medicines Production Volume Share by Region (2018-2023)

    • Figure China Geriatric Medicines Production Volume Share by Region (2018-2023)

    • Table China Geriatric Medicines Production Value by Region (2018-2023)

    • Table China Geriatric Medicines Production Value Share by Region (2018-2023)

    • Figure China Geriatric Medicines Production Value Share by Region (2018-2023)

    • Table China Geriatric Medicines Sales Volume by Region (2018-2023)

    • Table China Geriatric Medicines Sales Volume Share by Region (2018-2023)

    • Figure China Geriatric Medicines Sales Volume Share by Region (2018-2023)

    • Table China Geriatric Medicines Sales Value by Region (2018-2023)

    • Table China Geriatric Medicines Sales Value Share by Region (2018-2023)

    • Figure China Geriatric Medicines Sales Value Share by Region (2018-2023)

    • Table North China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table North China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure North China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table North China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table North China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure North China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table Central China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table Central China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure Central China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table Central China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table Central China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure Central China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table South China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table South China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure South China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table South China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table South China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure South China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table East China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table East China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure East China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table East China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table East China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure East China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table Northeast China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table Northeast China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table Northeast China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table Southwest China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table Southwest China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table Southwest China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Geriatric Medicines Production Volume by Type (2018-2023)

    • Table Northwest China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Geriatric Medicines Production Volume Share by Type (2018-2023)

    • Table Northwest China Geriatric Medicines Sales Volume by Application (2018-2023)

    • Table Northwest China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Geriatric Medicines Sales Volume Share by Application (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca plc Company Profile

    • Table AstraZeneca plc Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories, Inc Company Profile

    • Table Abbott Laboratories, Inc Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Merck & Company Inc Company Profile

    • Table Merck & Company Inc Geriatric Medicines Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Geriatric Medicines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US